Abstract |
A series of fluorinated-phenylsulfamates have been prepared by sulfamoylation of the corresponding phenols and the inhibition of four physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isozymes, the cytosolic CA I and II (off-targets), and the transmembrane, tumor-associated CA IX and XII is investigated. Unlike the lead molecule (phenylsulfamate), a very potent CA I and II inhibitor and a modest CA IX/XII inhibitor, the fluorinated sulfamates were stronger inhibitors of CA IX (K(I)s of 2.8-47 nM) and CA XII (K(I)s of 1.9-35 nM) than of CA I (K(I)s of 53-415 nM) and CA II (K(I)s of 20-113 nM). Some of these compounds were selective CA IX over CA II inhibitors, with selectivity ratios in the range of 11.4-12.1, making them interesting candidates for targeting hypoxic tumors overexpressing CA IX and/or XII.
|
Authors | Jean-Yves Winum, Alessio Innocenti, Daniela Vullo, Jean-Louis Montero, Claudiu T Supuran |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 19
Issue 17
Pg. 5082-5
(Sep 01 2009)
ISSN: 1464-3405 [Electronic] England |
PMID | 19632111
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- Carbonic Anhydrase Inhibitors
- Protein Isoforms
- Sulfonic Acids
- sulfamic acid
- Carbonic Anhydrase I
- Carbonic Anhydrase II
- CA9 protein, human
- Carbonic Anhydrase IX
- Carbonic Anhydrases
- carbonic anhydrase XII
|
Topics |
- Antigens, Neoplasm
(metabolism)
- Carbonic Anhydrase I
(antagonists & inhibitors)
- Carbonic Anhydrase II
(antagonists & inhibitors)
- Carbonic Anhydrase IX
- Carbonic Anhydrase Inhibitors
(chemistry, pharmacology)
- Carbonic Anhydrases
(chemistry, metabolism)
- Catalytic Domain
- Humans
- Protein Isoforms
(antagonists & inhibitors, metabolism)
- Structure-Activity Relationship
- Sulfonic Acids
(chemistry, pharmacology)
|